Top Markets
#1 Black Phoenix Black Phoenix +860.29%
#2 QuantixAI QuantixAI +102.63%
#3 MetaDAO MetaDAO +26.72%
#4 Pons Pons +23.08%
#5 LayerZero LayerZero +20.52%
#6 Ontology Gas Ontology Gas +19.80%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +19.11%
#8 Bedrock Bedrock +18.57%
#9 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.04%
#10 SPX6900 SPX6900 +15.41%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Shanghai Pharmaceuticals Holding Co., Ltd Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd

601607
Classement en actions #2388
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Prix de l'action
$2.37
Capitalisation boursière
$8.80B
Changement (1 jour)
1.11%
Changement (1 an)
-12.91%
Pays
CN
Échange Shanghai Pharmaceuticals Holding Co., Ltd (601607)

Catégorie

Healthcare
Bénéfices pour Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Shanghai Pharmaceuticals Holding Co., Ltd, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Shanghai Pharmaceuticals Holding Co., Ltd de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
$6.46B -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
- -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
$2.17B -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
- -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
$358.16M -
AU